THERAPY WITH CISPLATIN AND ETOPOSIDE FOR NON-SMALL-CELL LUNG-CANCER

被引：0
|
作者：
KLASTERSKY, J [1 ]
机构：
[1] UNIV LIBRE BRUXELLES,CTR TUMEURS,INST JULES BORDET,HJ TAGNON LAB CLIN INVEST,B-1000 BRUSSELS,BELGIUM
来源：
SEMINARS IN ONCOLOGY | 1986年 / 13卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：104 / 114
页数：11
相关论文
共 50 条
  • [31] PHARMACODYNAMICS OF PROLONGED ORAL ETOPOSIDE IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER
    MILLER, AA
    TOLLEY, EA
    NIELL, HB
    GRIFFIN, JP
    MAUER, AM
    JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (06) : 1179 - 1188
  • [32] ADRIAMYCIN AND ETOPOSIDE WITH CISPLATIN OR CYCLOPHOSPHAMIDE IN THE TREATMENT OF SMALL CELL LUNG-CANCER
    SCULIER, JP
    KLASTERSKY, J
    WEERTS, D
    KENIS, Y
    LUSTMAN, J
    BECQUART, D
    MICHEL, J
    DEBUSSCHER, L
    NICAISE, C
    LONGEVAL, E
    MAIRESSE, M
    LEDENT, C
    LIBERT, P
    CHATTOU, O
    RAVEZ, P
    DEVRIENDT, J
    ROCMANS, P
    SCHMERBER, J
    BALASSE, P
    YERNAULT, JC
    DECOSTER, A
    DIERCKX, P
    FEREMANS, W
    BONDUE, H
    PARIDAENS, R
    EUROPEAN JOURNAL OF RESPIRATORY DISEASES, 1982, 63 : 43 - 44
  • [33] CHEMOTHERAPY OF NON-SMALL-CELL LUNG-CANCER
    KLASTERSKY, J
    SCULIER, JP
    SEMINARS IN ONCOLOGY, 1985, 12 (04) : 38 - 48
  • [34] ETOPOSIDE, IFOSFAMIDE, AND CISPLATIN IN EXTENSIVE SMALL-CELL LUNG-CANCER
    LOEHRER, PJ
    RYNARD, S
    ANSARI, R
    SONGER, J
    PENNINGTON, K
    EINHORN, L
    CANCER, 1992, 69 (03) : 669 - 673
  • [35] CHEMOTHERAPY IN NON-SMALL-CELL LUNG-CANCER
    THATCHER, N
    RANSON, M
    LEE, SM
    NIVEN, R
    ANDERSON, H
    ANNALS OF ONCOLOGY, 1995, 6 : 83 - 95
  • [36] CHEMOTHERAPY OF ADVANCED NON-SMALL-CELL LUNG-CANCER WITH CYCLOPHOSPHAMIDE, ADRIAMYCIN, METHOTREXATE, AND PROCARBAZINE VERSUS CISPLATIN AND ETOPOSIDE - A RANDOMIZED STUDY
    VERONESI, A
    MAGRI, MD
    TIRELLI, U
    CARBONE, A
    MAZZA, F
    FRANCESCHI, S
    TALAMINI, R
    ARDIZZONI, A
    CANOBBIO, L
    ROSSO, R
    MONFARDINI, S
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (05): : 566 - 571
  • [37] ROLE OF SYSTEMIC THERAPY IN ADVANCED NON-SMALL-CELL LUNG-CANCER
    VOKES, EE
    VIJAYAKUMAR, S
    BITRAN, JD
    HOFFMAN, PC
    GOLOMB, HM
    AMERICAN JOURNAL OF MEDICINE, 1990, 89 (06) : 777 - 786
  • [38] ADVANCES IN SURGICAL STAGING AND THERAPY OF NON-SMALL-CELL LUNG-CANCER
    SUGARBAKER, DJ
    STRAUSS, GM
    SEMINARS IN ONCOLOGY, 1993, 20 (02) : 163 - 172
  • [39] CISPLATIN AND ETOPOSIDE IN THE TREATMENT OF NON SMALL CELL LUNG-CANCER STAGE-III M
    SCAGLIOTTI, G
    LODICO, D
    GOZZELINO, F
    BARDESSONO, F
    ALBERA, C
    PESCETTI, G
    INVESTIGATIONAL NEW DRUGS, 1984, 2 (01) : 123 - 123
  • [40] LONG-TERM RESULTS OF NEOADJUVANT IFOSFAMIDE, CISPLATIN, AND ETOPOSIDE COMBINATION IN LOCALLY ADVANCED NON-SMALL-CELL LUNG-CANCER
    PUJOL, JL
    HAYOT, M
    ROUANET, P
    LECHEVALIER, T
    MICHEL, FB
    CHEST, 1994, 106 (05) : 1451 - 1455
12345